Profiles of Intraday Glucose in Type 2 Diabetes and Their Association with Complications: An Analysis of Continuous Glucose Monitoring Data

被引:16
|
作者
Varghese, Jithin Sam [1 ]
Ho, Joyce C. [2 ]
Anjana, Ranjit Mohan [3 ,4 ]
Pradeepa, Rajendra [3 ,4 ]
Patel, Shivani A. [5 ]
Jebarani, Saravanan [3 ,4 ]
Baskar, Viswanathan [3 ,4 ]
Narayan, K. M. Venkat [5 ]
Mohan, Viswanathan [3 ,4 ]
机构
[1] Emory Univ, Laney Sch Grad Studies, Nutr & Hlth Sci Doctoral Program, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Comp Sci, Atlanta, GA 30322 USA
[3] Dr Mohans Diabet Special Ctr, Dept Diabetol, Chennai 600086, Tamil Nadu, India
[4] Madras Diabet Res Fdn, Chennai, Tamil Nadu, India
[5] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA
关键词
Ambulatory glucose profile; Cluster analysis; Glycemic variability; Time in range; URBAN-RURAL EPIDEMIOLOGY; BLOOD-GLUCOSE; GLYCEMIC CONTROL; CLUSTER-ANALYSIS; ASIAN INDIANS; VARIABILITY; RETINOPATHY; ADULTS; RISK; HYPOGLYCEMIA;
D O I
10.1089/dia.2020.0672
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To identify profiles of type 2 diabetes from continuous glucose monitoring (CGM) data using ambulatory glucose profile (AGP) indicators and examine the association with prevalent complications. Methods: Two weeks of CGM data, collected between 2015 and 2019, from 5901 adult type 2 diabetes patients were retrieved from a clinical database in Chennai, India. Non-negative matrix factorization was used to identify profiles as per AGP indicators. The association of profiles with existing complications was examined using multinomial and logistic regressions adjusted for glycated hemoglobin (HbA1c; %), sex, age at onset, and duration of diabetes. Results: Three profiles of glycemic variability (GV) were identified based on CGM data-Profile 1 ["TIR Profile"] (n = 2271), Profile 2 ["Hypo"] (n = 1471), and Profile 3 ["Hyper"] (n = 2159). Compared with time in range (TIR) profile, those belonging to Hyper had higher mean fasting plasma glucose (202.9 vs. 167.1, mg/dL), 2-h postprandial plasma glucose (302.1 vs. 255.6, mg/dL), and HbA1c (9.7 vs. 8.6; %). Both "Hypo profile" and "Hyper profile" had higher odds of nonproliferative diabetic retinopathy ("Hypo": 1.44, 1.20-1.73; "Hyper": 1.33, 1.11-1.58), macroalbuminuria ("Hypo": 1.58, 1.25-1.98; "Hyper": 1.37, 1.10-1.71), and diabetic kidney disease (DKD; "Hypo": 1.65, 1.18-2.31; "Hyper": 1.88, 1.37-2.58), compared with "TIR profile." Those in "Hypo profile" (vs. "TIR profile") had higher odds of proliferative diabetic retinopathy (PDR; 2.84, 1.65-2.88). Conclusions: We have identified three profiles of GV from CGM data. While both "Hypo profile" and "Hyper profile" had higher odds of prevalent DKD compared with "TIR profile," "Hypo profile" had higher odds of PDR. Our study emphasizes the clinical importance of recognizing and treating hypoglycemia (which is often unrecognized without CGM) in patients with type 2 Diabetes Mellitus.
引用
收藏
页码:555 / 564
页数:10
相关论文
共 50 条
  • [41] Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes
    Carlson, Anders L.
    Mullen, Deborah M.
    Bergenstal, Richard M.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 : S4 - S11
  • [42] Model Identification using Continuous Glucose Monitoring Data for Type 1 Diabetes
    Boiroux, Dimitri
    Hagdrup, Morten
    Mahmoudi, Zeinab
    Poulsen, Niels Kjolstad
    Madsen, Henrik
    Jorgensen, John Bagterp
    [J]. IFAC PAPERSONLINE, 2016, 49 (07): : 759 - 764
  • [43] Continuous Glucose Monitoring in Youth with Type 1 Diabetes
    Wadwa, R. Paul
    Fiallo-Scharer, Rosanna
    VanderWel, Brandon
    Messer, Laurel H.
    Cobry, Erin
    Chase, H. Peter
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 : S83 - S91
  • [44] Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real-world analysis
    Garg, Satish K.
    Hirsch, Irl B.
    Repetto, Enrico
    Snell-Bergeon, Janet
    Ulmer, Brian
    Perkins, Christopher
    Bergenstal, Richard M.
    [J]. DIABETES OBESITY & METABOLISM, 2024,
  • [45] Continuous Glucose Monitoring and Type 1 Diabetes Reply
    Tamborlane, William V.
    Beck, Roy W.
    Laffel, Lori
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (02): : 191 - 192
  • [46] Continuous glucose monitoring in type 1 diabetes mellitus
    Pavlicek, Vojtech
    [J]. DIABETOLOGE, 2019, 15 (08): : 744 - 746
  • [47] Continuous glucose monitoring in type 1 diabetes mellitus
    Tamborlane, William V.
    Beck, Roy W.
    [J]. LANCET, 2009, 373 (9677): : 1744 - 1746
  • [48] Continuous glucose monitoring in children with type 1 diabetes
    不详
    [J]. JOURNAL OF PEDIATRICS, 2007, 151 (04): : 388 - 393
  • [49] Sustained Benefit of Continuous Glucose Monitoring on A1C, Glucose Profiles, and Hypoglycemia in Adults With Type 1 Diabetes
    Beck, Roy W.
    Xing, Dongyuan
    Gilliam, Lisa
    Hirsch, Irl
    Kollman, Craig
    Laffel, Lori
    Ruedy, Katrina J.
    Tamborlane, William V.
    Weinzimer, Stuart
    Wolpert, Howard
    [J]. DIABETES CARE, 2009, 32 (11) : 2047 - 2049
  • [50] Value of Capillary Glucose Profiles in Assessing Risk of Nocturnal Hypoglycemia in Type 1 Diabetes Based on Continuous Glucose Monitoring
    Ling, Qing
    Lu, Jing
    Li, Xiang
    Qiao, Chengcheng
    Zhu, Dalong
    Bi, Yan
    [J]. DIABETES THERAPY, 2020, 11 (04) : 915 - 925